|
2019
|
Invention
|
Antitumour combinations containing a vegf inhibiting agent and irinotecan.
Disclosed are antitum... |
|
|
Invention
|
Novel antitumoral use of cabazitaxel.
The invention relates to a compound of formula:
The inve... |
|
2017
|
Invention
|
Antitumoral combination comprising cabazitaxel and cisplatin.
The present invention relates to a... |
|
|
Invention
|
Crystalline forms of dimethoxy docetaxel and methods for preparing the same. The invention relate... |
|
|
Invention
|
Methods and compositions for diseases associated with amyloidosis.
The present invention general... |
|
2016
|
Invention
|
Cabazitaxel and its use for treating metastatic prostate cancers.
The present disclosure relates... |
|
|
Invention
|
Mutations of the parkin gene, compositions, methods and uses.
The invention concerns nucleic aci... |
|
|
Invention
|
Cabazitaxel and its use for treating cancer. The present invention relates to the compound having... |
|
|
Invention
|
Cabazitaxel and its use for treating cancer.
The present invention relates to the compound havin... |
|
|
Invention
|
Crystalline form of cabazitaxel and process for preparing the same.
The present invention relate... |
|
2015
|
Invention
|
Use of cabazitaxel for the treatment of gastric adenocarcinoma. The invention relates to a compou... |
|
2014
|
Invention
|
Use of cabazitaxel in patients with metastatic nsclc progressing after docetaxel-based treatment.... |
|
|
Invention
|
Mutations of the parkin gene, compositions, methods and uses. The invention concerns nucleic acid... |
|
|
Invention
|
Pediatric uses of cabazitaxel.
The present invention relates to the compound of formula (I):
T... |
|
|
Invention
|
Crystalline forms of dimethoxy docetaxel and methods for preparing the same.
The invention relat... |
|
|
Invention
|
Crystalline form of cabazitaxel and process for preparing the same. The present invention relates... |
|
|
Invention
|
Cabazitaxel and its use for treating metastatic prostate cancers. The present invention relates t... |
|
2013
|
Invention
|
Pharmaceutical composition comprising ketoprofen.
The present invention relates to a pharmaceuti... |
|
|
Invention
|
Solid pharmaceutical composition comprising telithromycin. This invention relates to a solid phar... |
|
|
Invention
|
Modified soluble fgf receptor fc fusions method.
The invention relates to modified soluble FGF r... |
|
|
Invention
|
Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereof.
This ... |
|
|
Invention
|
New pediatric uses of cabazitaxel. The present invention relates to the compound of formula (I): ... |
|
|
Invention
|
Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary ar... |
|
2012
|
Invention
|
Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing majo... |
|
|
Invention
|
Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having... |
|
|
Invention
|
Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safet... |
|
|
Invention
|
Semuloparin for improving the survival of patients with cancer. The invention relates to an ultra... |
|
|
Invention
|
Recombinant adenoviruses encoding the specific iodine transporter (nis). The present invention re... |
|
|
Invention
|
Pharmaceutical composition comprising ketoprofen. The present invention relates to a pharmaceutic... |
|
|
Invention
|
Semuloparin for the prevention of venous thromboembolism in cancer patients receiving chemotherap... |
|
|
Invention
|
Compositions for topical application having androgenic actions.
A composition comprising at leas... |
|
|
Invention
|
Antitumoral combination comprising cabazitaxel and cisplatin. The present invention relates to a ... |
|
|
Invention
|
Modified soluble fgf receptor fc fusions method. The invention relates to modified soluble FGF re... |
|
2011
|
Invention
|
New methods for the in vitro measurement of the biological activity of an ultra low molecular wei... |
|
|
Invention
|
Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdo... |
|
|
Invention
|
Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safet... |
|
|
Invention
|
Mutations of the parkin gene. The invention concerns nucleic acids coding for mutated or truncate... |
|
|
Invention
|
Method for identifying an antagonist of guanine nucleotide releasing factor 1. The invention conc... |
|
2006
|
G/S
|
Pharmaceutical products. |
|
2004
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical products. Pharmaceutical, medical and scientific research and
development service... |
|
|
G/S
|
Insulin-based products. Medical devices and apparatus, namely insulin pens; blood
glucose monitors. |
|
2002
|
Invention
|
Transgeneic animal expressing a multiple mutated form of presenilin 1. The present invention rela... |
|
2000
|
G/S
|
Pharmaceutical products, namely, antibiotics. |
|
1996
|
G/S
|
Pharmaceutical, veterinary and sanitary products. |
|
1986
|
G/S
|
Produits pharmaceutiques. |
|
1985
|
G/S
|
Produits pharmaceutiques, vétérinaires et hygiéniques;
substances diététiques à usage médical, a... |
|
|
G/S
|
Pharmaceutical, veterinary and sanitary products; dietetic
substances adapted for medical use, f... |
|
1978
|
G/S
|
Produits pharmaceutiques et hygiéniques; produits
diététiques pour enfants et malades; emplâtres... |
|
1968
|
G/S
|
Une revue psychiatrique. |
|
1966
|
G/S
|
Pharmaceutical products, for special use or not, dressings,
disinfectants, veterinary products. |
|
1958
|
G/S
|
Produits pharmaceutiques, vétérinaires, hygiéniques et
diététiques, emplâtres, matériel pour pan... |
|
1956
|
G/S
|
Tous produits pharmaceutiques, spéciaux ou non, objets
pour pansements, désinfectants, produits ... |
